R&D Portfolio Management, VC-Style
This article was originally published in Start Up
Executive Summary
Take a group of R&D executives and give them a venture fund. What you get is a fund that looks an awful lot like a pharmaceutical company's R&D portfolio. The new fund is Basel-based Biomedicines Private Equity Holding, and it's run by Jurgen Drews, MD, the former president of Roche's worldwide research; Fritz Buhler, MD, a former head of clinical research; and Stefan Ryser, Drews' former chief of staff.